Sinemet and Aubagio drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Sinemet (carbidopa; levodopa) and Aubagio (teriflunomide). Common drug interactions include alopecia among females and surgery among males.

The phase IV clinical study analyzes what interactions people have when they take Sinemet and Aubagio. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Sinemet?

Sinemet has active ingredients of carbidopa; levodopa. It is often used in parkinson's disease. eHealthMe is studying from 29,601 Sinemet users. Check the latest studies of Sinemet.

What is Aubagio?

Aubagio has active ingredients of teriflunomide. It is often used in multiple sclerosis. eHealthMe is studying from 50,041 Aubagio users. Check the latest studies of Aubagio.



On Jul, 10, 2026

18 people who take Sinemet and Aubagio together, and have interactions are studied.

Sinemet and Aubagio drug interactions.

What are the common drug interactions of Sinemet and Aubagio, by gender? *:

female:

  1. Alopecia (absence of hair from areas of the body)
  2. Nasopharyngitis (inflammation of the nasopharynx)
  3. Deafness
  4. Depressed mood
  5. Dry throat
  6. Dysstasia (difficulty in standing)
  7. Gait disturbance
  8. Peroneal nerve palsy
  9. Rash erythematous (redness of the skin)
  10. Rhinitis (a medical term for irritation and inflammation of the mucous membrane inside the nose)

male:

  1. Surgery
  2. Anxiety
  3. Cartilage atrophy (cartilage extra growth)
  4. Device dislocation
  5. Device occlusion
  6. Freezing phenomenon
  7. Gastric disorder (disease of stomach)
  8. Hospitalisation
  9. Joint dislocation (a joint position is changed from normal position)
  10. Oropharyngeal pain

What are the common drug interactions of Sinemet and Aubagio, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Blood pressure increased
  2. Cough
  3. Deafness
  4. Depressed mood
  5. Dry throat
  6. Dysstasia (difficulty in standing)
  7. Gait disturbance
  8. Nasopharyngitis (inflammation of the nasopharynx)
  9. Nephrolithiasis (calculi in the kidneys)
  10. Peroneal nerve palsy

60+:

  1. Surgery
  2. Alopecia (absence of hair from areas of the body)
  3. Device dislocation
  4. Device occlusion
  5. Dyskinesia (abnormality or impairment of voluntary movement)
  6. Fall
  7. Freezing phenomenon
  8. Headache (pain in head)
  9. Hearing impaired
  10. Memory impairment

What are the existing conditions these people have? *

  1. Stress And Anxiety: 4 people, 22.22%
  2. Restless Leg Syndrome (a powerful urge to move your legs): 4 people, 22.22%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 16.67%
  4. Muscle Spasms (muscle contraction): 3 people, 16.67%
  5. Nasal Congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels): 3 people, 16.67%
  6. Urinary Tract Infection: 2 people, 11.11%
  7. Oral Herpes (viral infection of mouth): 2 people, 11.11%
  8. Constipation: 2 people, 11.11%
  9. Dementia (madness): 2 people, 11.11%
  10. Depression: 2 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Sinemet and Aubagio?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Sinemet and Aubagio:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Sinemet:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Aubagio:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Sinemet and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Aubagio and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on carbidopa; levodopa and teriflunomide (the active ingredients of Sinemet and Aubagio, respectively), and Sinemet and Aubagio (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: